Movement Alert｜INNOVENT BIO Falls 3.31% in Regular Trading, Trading at 96.35 HKD

Market Focus

Sep 28

On September 28, INNOVENT BIO fell 3.31% in regular trading, trading at 96.35 HKD/share, with Turnover of HKD 156 million.

Within the Biotechnology sector where INNOVENT BIO belongs, sector performance was mixed. Among individual stocks, AKESO down 1.98%, BEONE MEDICINES up 1.39%, CANSINOBIO up 3.49%, REMEGEN down 1.10%, 3SBIO down 0.69%.

INNOVENT BIO is a leading biopharmaceutical company principally engaged in the research, development, manufacturing, and commercialization of innovative drugs for the treatment of oncology, cardiovascular and metabolic, autoimmune, and ophthalmic diseases. Its drug modalities include monoclonal antibodies, multispecific antibodies, immune cytokines, antibody-drug conjugates (ADC), cell therapies, and small molecule drugs. Key marketed products include Sintilimab, Bevacizumab, Adalimumab, Rituximab, and Pemigatinib, with operations spanning domestic and overseas markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1124757372"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124757372\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124757372?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-28 10:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124757372","market":"us","top_or_hot":-1,"title":"Movement Alert｜INNOVENT BIO Falls 3.31% in Regular Trading, Trading at 96.35 HKD","media":"Market Focus","content":"<p><p>On September 28, INNOVENT BIO fell 3.31% in regular trading, trading at 96.35 HKD/share, with Turnover of HKD 156 million.</p><p>Within the Biotechnology sector where INNOVENT BIO belongs, sector performance was mixed. Among individual stocks, AKESO down 1.98%, BEONE MEDICINES up 1.39%, CANSINOBIO up 3.49%, REMEGEN down 1.10%, 3SBIO down 0.69%.</p><p>INNOVENT BIO is a leading biopharmaceutical company principally engaged in the research, development, manufacturing, and commercialization of innovative drugs for the treatment of oncology, cardiovascular and metabolic, autoimmune, and ophthalmic diseases. Its drug modalities include monoclonal antibodies, multispecific antibodies, immune cytokines, antibody-drug conjugates (ADC), cell therapies, and small molecule drugs. Key marketed products include Sintilimab, Bevacizumab, Adalimumab, Rituximab, and Pemigatinib, with operations spanning domestic and overseas markets.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INNOVENT BIO Falls 3.31% in Regular Trading, Trading at 96.35 HKD</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INNOVENT BIO Falls 3.31% in Regular Trading, Trading at 96.35 HKD\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-28 10:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 28, INNOVENT BIO fell 3.31% in regular trading, trading at 96.35 HKD/share, with Turnover of HKD 156 million.</p><p>Within the Biotechnology sector where INNOVENT BIO belongs, sector performance was mixed. Among individual stocks, AKESO down 1.98%, BEONE MEDICINES up 1.39%, CANSINOBIO up 3.49%, REMEGEN down 1.10%, 3SBIO down 0.69%.</p><p>INNOVENT BIO is a leading biopharmaceutical company principally engaged in the research, development, manufacturing, and commercialization of innovative drugs for the treatment of oncology, cardiovascular and metabolic, autoimmune, and ophthalmic diseases. Its drug modalities include monoclonal antibodies, multispecific antibodies, immune cytokines, antibody-drug conjugates (ADC), cell therapies, and small molecule drugs. Key marketed products include Sintilimab, Bevacizumab, Adalimumab, Rituximab, and Pemigatinib, with operations spanning domestic and overseas markets.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01801","symbol_name":"信达生物","start_time":0,"source_url":"","article_id":"1124757372","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124757372","pubTimestamp":1790561367,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 28, INNOVENT BIO fell 3.31% in regular trading, trading at 96.35 HKD/share, with Turnover of HKD 156 million.Within the Biotechnology sector where INNOVENT BIO belongs, sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01801":"信达生物"},"translate_title":"走势提醒|信达生物常规交易跌3.31%，报96.35港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":1},"content_text":"On September 28, INNOVENT BIO fell 3.31% in regular trading, trading at 96.35 HKD/share, with Turnover of HKD 156 million.Within the Biotechnology sector where INNOVENT BIO belongs, sector performance was mixed. Among individual stocks, AKESO down 1.98%, BEONE MEDICINES up 1.39%, CANSINOBIO up 3.49%, REMEGEN down 1.10%, 3SBIO down 0.69%.INNOVENT BIO is a leading biopharmaceutical company principally engaged in the research, development, manufacturing, and commercialization of innovative drugs for the treatment of oncology, cardiovascular and metabolic, autoimmune, and ophthalmic diseases. Its drug modalities include monoclonal antibodies, multispecific antibodies, immune cytokines, antibody-drug conjugates (ADC), cell therapies, and small molecule drugs. Key marketed products include Sintilimab, Bevacizumab, Adalimumab, Rituximab, and Pemigatinib, with operations spanning domestic and overseas markets.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}